Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
Schizophrenia, Medication Adherence, Medication Compliance
About this trial
This is an interventional supportive care trial for Schizophrenia focused on measuring Schizophrenia, Medication Adherence, Randomized control trail,community, schizophrenia
Eligibility Criteria
Inclusion Criteria: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis of schizophrenia group, including schizophrenia, affective schizophrenia (schizoaffective disorder); Age between 20 and 64 years old; At least one oral antipsychotic drugs; Living in the community, not participating in day wards, community rehabilitation centers and other rehabilitation institutions on weekdays, no psychiatric outpatient clinics, only home visits by home nurses; Those who can communicate in Chinese and Taiwanese Exclusion Criteria: Those who have a diagnosis related to organic problems, substance abuse, dementia or mental retardation, and are unable to communicate; Those who have received long-acting injections from the psychiatric department. -
Sites / Locations
- National Taipei University of Nursing and Health Sciences
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
experimental
control
Members of the experimental group received routine home visits( by psychiatric mental nurses, and the nurse provided patients with answers to questions about medications or care and handling of life events), and plus a 1-hour theory based integrated program intervention for 12 times in the 1st, 3rd, 5th, 7th, 9th, 11th, 13th, 15th, 17th, 19th, 21st, and 23rd weeks, and each patient received a total of 12 hours of intervention.
The control group received routine home visits by psychiatric mental nurses, and the nurse provided patients with answers to questions about medications or care and handling of life events. The visits and intervention time frequency were the same as those in the experimental group.